Accessing drug treatment programs in Atlantic Canada: the experiences of people who use substances

References

• Ashford, R. D., Brown, A. M., & Curtis, B. (2018). Systemic barriers in substance use disorder treatment: A prospective qualitative study of professionals in the field. Drug and Alcohol Dependence, 189, 62–69. https://doi.org/10.1016/j.drugalcdep.2018.04.033
   PubMed Web of Science ®Google Scholar
• Barnett, E. R., Knight, E., Herman, R. J., Amarakaran, K., & Jankowski, M. K. (2021). Difficult binds: A systematic review of facilitators and barriers to treatment among mothers with substance use disorders. Journal of Substance Abuse Treatment, 126, 108341. https://doi.org/10.1016/j.jsat.2021.108341
   PubMed Web of Science ®Google Scholar
• Belzak, L., & Halverson, J. (2018). The opioid crisis in Canada: A national perspective. Health Promotion and Chronic Disease Prevention in Canada, 38(6), 224–233. https://doi.org/10.24095/hpcdp.38.6.02
   PubMed Web of Science ®Google Scholar
• Bourgois, P. (2000). Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24(2), 165–195. https://doi.org/10.1023/a:1005574918294
   PubMed Web of Science ®Google Scholar
• British Columbia Centre on Substance Use. (n.d.). Opioid agonist treatment, general information. Retrieved from https://bcpsqc.ca/wp-content/uploads/2020/03/BCCSU-Handout-1-General-Info-on-OAT.pdf
   Google Scholar
• British Columbia Ministry of Mental Health and Addictions. (n.d.). Escalating BC’s response to the overdose emergency. Retrieved from https://www2.gov.bc.ca/assets/gov/overdose-awareness/mmha_escalating_bcs_response_report_final_26feb.pdf
   Google Scholar
• Bunting, A. M., Oser, C. B., Staton, M., Eddens, K. S., & Knudson, H. (2018). Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: A social ecological approach. Addiction Science and Clinical Practice, 13 (23), 1–10. https://doi.org/10.1186/s13722-018-0124-2
   PubMed Web of Science ®Google Scholar
• Buxton, J.A., & Panessa, C. (2009). Harm reduction in British Columbia. British Columbia Medical Journal, 51(4), 158–159.
   Google Scholar
• Canadian Drug Policy Coalition. (2021). Decriminalization done right: A Rights-based path for drug policy. https://www.drugpolicy.ca/decrim-done-right/
   Google Scholar
• Canadian Public Health Association. (2016). The opioid crisis in Canada. Retrieved from https://www.cpha.ca/sites/default/files/uploads/policy/positionstatements/opioid-positionstatement-e.pdf
   Google Scholar
• Chan Carusone, S., Guta, A., Robinson, S., Tan, D. H., Cooper, C., O’Leary, B., de Prinse, K., Cobb, G., Upshur, R., & Strike, C. (2019). Maybe if I stop the drugs, then maybe they’d Care?-Hospital care experiences of people who use drugs. Harm Reduction Journal, 16(1), 16. https://doi.org/10.1186/s12954-019-0285-7
   PubMedGoogle Scholar
• Challacombe, L. (2019). The epidemiology of hepatitis C in Canada. CATIE. Retrieved from https://www.catie.ca/the-epidemiology-of-hepatitis-c-in-canada-0
   Google Scholar
• Cooper, H. L. F., Bossak, B., Tempalski, B., Des Jarlais, D. C., & Friedman, S. R. (2009). Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programs. The International Journal on Drug Policy, 20(3), 217–226. https://doi.org/10.1016/j.drugpo.2008.08.008
   PubMed Web of Science ®Google Scholar
• Davis, T. (2020). March 4). Would a regional physician licence bring more doctors to P.E.I.? CBC News. https://www.cbc.ca/news/canada/prince-edward-island/pei-doctors-licence-march-2020-1.5486158
   Google Scholar
• Eibl, J. K., Morin, K., Leinonen, E., & Marsh, D. C. (2017). The state of opioid agonist therapy in Canada 20 years after federal oversight. Canadian Journal of Psychiatry. Revue canadienne de psychiatrie, 62(7), 444–450. https://doi.org/10.1177/0706743717711167
   PubMed Web of Science ®Google Scholar
• Elms, N., Link, K., Newman, A., & Brogly, S. B. and for the Kingston House of Recovery for Women and Children (2018). Need for women-centered treatment for substance use disorders: Results from focus group discussions. Harm Reduction Journal, 15(40), 1-8. https://doi.org/10.1186/s12954-018-0247-5
   PubMedGoogle Scholar
• Fischer, B., Chin, A. T., Kuo, I., Kirst, M., & Vlahov, D. (2002). Canadian illicit opiate users’ views on methadone and other opiate prescription treatment: An exploratory qualitative study. Substance Use & Misuse, 37(4), 495–522. https://doi.org/10.1081/ja-120002807
   PubMed Web of Science ®Google Scholar
• Frank, D., Mateu-Gelabert, P., Perlman, D. C., Walters, S. M., Curran, L., & Guarino, H. (2021). It’s like ‘liquid handcuffs’: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives. Harm Reduction Journal, 18(1), 88. https://doi.org/10.1186/s12954-021-00535-y
   PubMed Web of Science ®Google Scholar
• Global Commission on Drug Policy. (2016). Advancing drug policy reform: A new approach to decriminalization. http://www.globalcommissionondrugs.org/wp-content/uploads/2016/11/GCDP-Report-2016-ENGLISH.pdf
   Google Scholar
• Government of Canada. (2021a). Canadian Alcohol and Drugs Survey (CADS): Summary of results for 2019. https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/2019-summary.html
   Google Scholar
• Government of Canada. (2021b). Canada-New Brunswick emergency treatment fund bilateral agreement. https://www.canada.ca/en/health-canada/services/opioids/responding-canada-opioid-crisis/emergency-treatment-fund/new-brunswick-2018.html
   Google Scholar
• Government of New Brunswick, Office of the Chief Medical Officer of Health. (2020). Opioid related harms in New Brunswick: Deaths, overdoses and take home naloxone kits 2020 – Quarter 1 & 2. https://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/MentalHealth/New-Brunswick_opioid-surveillance-report_2020-Q1-2.pdf
   Google Scholar
• Government of Prince Edward Island. (2022, June). Preventing opioid-related overdoses. https://www.princeedwardisland.ca/en/information/health-and-wellness/preventing-opioid-related-overdoses
   Google Scholar
• Greer, A. (2021). Decriminalizing drug use is a necessary step, but it won’t end the opioid overdose crisis. The Conversation. https://theconversation.com/decriminalizing-drug-use-is-a-necessary-step-but-it-wont-end-the-opioid-overdose-crisis-162497
   Google Scholar
• Have you heard about the hub and spoke model? (2021). Presentation to the College of Registered Nurses of Newfoundland and Labrador. Retrieved from https://crnnl.ca/event/have-you-heard-about-the-provincial-hub-and-spoke-model/
   Google Scholar
• Hayashi, K., Ti, L., Ayutthaya, P. P. N., Suwannawong, P., Kaplan, K., Small, W., & Kerr, T. (2017). Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: A mixed-methods study. Harm Reduction Journal, 14(63), 1-8. https://doi.org/10.1186/s12954-017-0189-3
   PubMedGoogle Scholar
• Hope, V. D., Parry, J. V., Ncube, F., & Hickman, M. (2016). Not in the vein: ‘Missed hits’, subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom. The International Journal on Drug Policy, 28, 83–90. https://doi.org/10.1016/j.drugpo.2015.11.003
   PubMed Web of Science ®Google Scholar
• Jacka, B., Larney, S., Degenhardt, L., Janjua, N., Høj, S., Krajden, M., Grebely, J., & Bruneau, J. (2020). Prevalence of injecting drug use and coverage of interventions to prevent HIV and Hepatitis C virus infection among people who inject drugs in Canada. American Journal of Public Health, 110(1), 45–50. https://doi.org/10.2105/AJPH.2019.305379
   PubMed Web of Science ®Google Scholar
• Jackson, L. A., Buxton, J.A., Dingwell, J., Dykeman, M., Gahagan, J., Gallant, K., Karabanow, J., Kirkland, S., LeVangie, D., Sketris, I., Gossop, M., & Davison, C. (2014). Improving psychosocial health and employment outcomes for individuals receiving methadone treatment: A realist synthesis of what makes interventions work. BMC Psychology, 2(26), 1–20. https://doi.org/10.1186/s40359-014-0026-3
   Google Scholar
• Jackson, L. A., & Strike, C. (2020). Harm reduction ‘on the move’: What is the role of environmental influences? Journal of Health Care for the Poor and Underserved, 31(2), 519–529.
   PubMed Web of Science ®Google Scholar
• Kiriazova, T., Go, V. F., Hershow, R. B., Hamilton, E. L., Sarasvita, R., Bui, Q., Lancaster, K. E., Dumchev, K., Hoffman, I. F., Miller, W. C., & Latkin, C. A. (2020). Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietman: HPTN 074 study. Harm Reduction Journal, 17(1), 13. https://doi.org/10.1186/s12954-020-00415-x
   PubMed Web of Science ®Google Scholar
• Kourounis, G., Richards, B. D. W., Kyprianou, E., Symeonidou, E., Malliori, M.-M., & Samartzis, L. (2016). Opioid substitution therapy: Lowering the treatment thresholds. Drug and Alcohol Dependence, 161, 1–8. https://doi.org/10.1016/j.drugalcdep.2015.12.021
   PubMed Web of Science ®Google Scholar
• Lachapelle, É., Archambault, L., Blouin, C., & Perreault, M. (2021). Perspectives of people with opioid use disorder on improving addiction treatments and services. Drug: Education, Prevention and Policy 28(4), 316–327. https://doi.org/10.1080/09687637.2020.1833837
   Web of Science ®Google Scholar
• Livingston, J. D., Adams, E., Jordan, M., MacMillan, Z., & Hering, R. (2018). Primary care physicians’ views about prescribing methadone to treat opioid use disorder. Substance Use & Misuse, 53(2), 344–353. https://doi.org/10.1080/10826084.2017.1325376
   PubMed Web of Science ®Google Scholar
• Lyons, T., Shannon, K., Pierre, L., Small, W., Krüsi, A., & Kerr, T. (2015). A qualitative study of transgender individuals’ experiences in residential addiction treatment settings: Stigma and inclusivity. Substance Abuse Treatment, Prevention, and Policy, 10, 17. https://doi.org/10.1186/s13011-015-0015-4
   PubMed Web of Science ®Google Scholar
• MacDonald, M. (1998). The impact of a restructured Canadian welfare state on Atlantic Canada. Social Policy and Administration, 32(4), 389–400. https://doi.org/10.1111/1467-9515.00122
   Web of Science ®Google Scholar
• Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., & Mattick, R. P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet, 372(9651), 1733–1745. https://doi.org/10.1016/S0140-6736(08)61311-2
   PubMed Web of Science ®Google Scholar
• McCutcheon, J. M., & Morrison, M. A. (2014). Injecting on the Island: A qualitative exploration of the service needs of persons who inject drugs in Prince Edward Island, Canada. Harm Reduction Journal, 11(10), 10–11. https://doi.org/10.1186/1477-7517-11-10
   PubMedGoogle Scholar
• McNeil, R., Small, W., Wood, E., & Kerr, T. (2014). Hospitals as a ‘risk environment’: An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Social Science & Medicine, 105, 59–66. https://doi.org/10.1016/j.socscimed.2014.01.010
   PubMed Web of Science ®Google Scholar
• Mills, J., Bonner, A., & Francis, K. (2006). The development of constructivist grounded theory. International Journal of Qualitative Methods, 5(1), 25–35. https://doi.org/10.1177/160940690600500103
   Google Scholar
• National Institute on Drug Abuse. (2018). Heroin research report. https://nida.nih.gov/publications/research-reports/heroin/what-are-long-term-effects-heroin-use
   Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378(9791), 571–583. https://doi.org/10.1016/S0140-6736(11)61097-0
   PubMed Web of Science ®Google Scholar
• Oscapella, E. (2012). Changing the frame: A new approach to drug policy in Canada. Canadian Drug Policy Coalition. https://www.drugpolicy.ca/wp-content/uploads/2015/02/CDPC_report_eng_v14_comp.pdf
   Google Scholar
• Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. The International Journal on Drug Policy, 57, 104–110. https://doi.org/10.1016/j.drugpo.2018.04.004
   PubMed Web of Science ®Google Scholar
• Parliament of Canada. (2021). Bill C-216. Retrieved from https://www.parl.ca/DocumentViewer/en/44-1/bill/C-216/first-reading
   Google Scholar
• Patrick, S. W., Buntin, M. B., Martin, P. R., Scott, T. A., Dupont, W., Richards, M., & Cooper, W. O. (2019). Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Substance Abuse, 40(3), 356–362. https://doi.org/10.1080/08897077.2018.1488336
   PubMed Web of Science ®Google Scholar
• Peterson, J. A., Schwartz, R. P., Mitchell, S. G., Reisinger, H. S., Kelly, S. M., O'Grady, K. E., Brown, B. S., & Agar, M. H. (2010). Why don’t out-of-treatment individuals enter methadone treatment programs? The International Journal on Drug Policy, 21(1), 36–42. https://doi.org/10.1016/j.drugpo.2008.07.004
   PubMed Web of Science ®Google Scholar
• Powell, K. G., Treitler, P., Peterson, N. A., Borys, S., & Hallcom, D. (2019). Promoting opioid overdose prevention and recovery: An exploratory study of an innovative intervention model to address opioid abuse. The International Journal on Drug Policy, 64, 21–29. https://doi.org/10.1016/j.drugpo.2018.12.004
   PubMed Web of Science ®Google Scholar
• Prangnell, A., Daly-Grafstein, B., Dong, H., Nolan, S., Milloy, M.-J., Wood, E., Kerr, T., & Hayashi, K. (2016). Factors associated with inability to access addiction treatment among people who inject drugs in Vancouver, Canada. Substance Abuse Treatment, Prevention, and Policy, 11(9), 8–9. https://doi.org/10.1186/s13011-016-0053-6
   PubMedGoogle Scholar
• Province of Nova Scotia. (2017). Nova Scotia’s opioid use and overdose framework. https://novascotia.ca/opioid/
   Google Scholar
• Province of Nova Scotia. (2021, February). Nova Scotia’s opioid use and overdose framework – Update February 2021. https://novascotia.ca/opioid/opioid-framework-update-february-2021.pdf
   Google Scholar
• Public Health Agency of Canada. (2020). HIV in Canada: 2019 Surveillance Highlights. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/hiv-2019-surveillance-highlights.html. [2020-11-11 version]
   Google Scholar
• Pullen, E., & Oser, C. (2014). Barriers to substance abuse treatment in rural and urban communities: A counselor perspective. Substance Use & Misuse, 49(7), 891–901. https://doi.org/10.3109/10826084.2014.891615
   PubMed Web of Science ®Google Scholar
• Reamy, J. (1994). Physician recruitment in rural Canada: Programs in New Brunswick, Newfoundland and Nova Scotia. The Journal of Rural Health, 10(2), 131–136. https://doi.org/10.1111/j.1748-0361.1994.tb00220.x
   PubMedGoogle Scholar
• Redko, C., Rapp, R. C., & Carlson, R. G. (2006). Waiting time as a barrier to treatment entry: Perceptions of substance users. Journal of Drug Issues, 36(4), 831–852. https://doi.org/10.1177/002204260603600404
   PubMed Web of Science ®Google Scholar
• Region of Peel (2019). Supervised consumption site needs assessment and feasibility study for the Region of Peel. https://www.peelregion.ca/opioids/pdf/consumption-site-needs-assessment.pdf
   Google Scholar
• Report to the Chief Coroner of British Columbia. (2022, March). BC Coroners Service Death Review Panel: A review of illicit drug toxicity deaths. https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/death-review-panel/review_of_illicit_drug_toxicity_deaths_2022.pdf
   Google Scholar
• Rhodes, T. (2002). The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13(2), 85–94. https://doi.org/10.1016/S0955-3959(02)00007-5
   Google Scholar
• Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. The International Journal on Drug Policy, 20(3), 193–201. https://doi.org/10.1016/j.drugpo.2008.10.003
   PubMed Web of Science ®Google Scholar
• River Stone Recovery Centre. (2021). Our services. https://www.riverstone.recoverynb.ca/
   Google Scholar
• Rockwell, R., Des Jarlais, D. C., Friedman, S. R., Perlis, T. E., & Paone, D. (1999). Geographic proximity, policy, and utilization of syringe exchange programmes. AIDS Care, 11(4), 437–442. https://doi.org/10.1080/09540129947811
   PubMed Web of Science ®Google Scholar
• Rush, B., Talbot, A., Ali, F., Bozinoff, N., Giang, V., Imtiaz, S., Elton-Marshall, T., Mbacfou, M., Russell, C., & Rehm, J. (2021). Environmental scan of withdrawal management practices and services in Canada: Response to opioid use disorder. Canadian Research Initiative in Substance Use. Toronto, Ontario. 87 pages. https://crism.ca/wp-content/uploads/2021/06/WMSFINALReportJune2021.pdf
   Google Scholar
• Schneidereit, P. (2021, May 21). Nova Scotia’s need for family doctors skyrockets, 65,000 people now on registry. Saltwire. https://www.saltwire.com/atlantic-canada/opinion/paul-schneidereit-nova-scotia-family-doctor-shortage-skyrockets-over-past-year-100591029/
   Google Scholar
• Schultz, N. R., Martinez, R., Cucciare, M. A., & Timko, C. (2016). Patient, program, and system barriers and facilitators to detoxification services in the U.S. Veterans Health Administration: A qualitative study of provider perspectives. Substance Use & Misuse, 51(10), 1330–1341. https://doi.org/10.3109/10826084.2016.1168446
   PubMed Web of Science ®Google Scholar
• Singh, V. (2002). Rural income disparities in Canada: A comparison across the provinces. Rural and Small Town Canada Analysis Bulletin, 3(7), 5xtz2ZaW. https://www150.statcan.gc.ca/n1/en/pub/21-006-x/21-006-x2001007-eng.pdf?st=5xtz2ZaW
   Google Scholar
• Smyth, G. (2022, January 2). Benzodiazepines ‘a major problem’ in illicit drug supply. CBC News. https://www.cbc.ca/news/canada/british-columbia/benzodiazepines-drug-supply-1.6287634
   Google Scholar
• Sorensen, J., Masson, C., & Perlman, D. (2002). HIV/Hepatitis prevention in drug abuse treatment programs: Guidance from research. Science & Practice Perspectives, 1(1), 4–11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851052/
   PubMedGoogle Scholar
• Special Advisory Committee on the Epidemic of Opioid Overdoses. (2022). Opioid- and Stimulant-related Harms in Canada. Public Health Agency of Canada. Retrieved March, 2022, from https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/
   Google Scholar
• Statistics Canada (2015, December). Proportion of the population living in rural areas, provinces and territories, 2006 and 2011. https://www12.statcan.gc.ca/census-recensement/2011/as-sa/98-310-x/2011003/fig/fig3_2-3-eng.cfm.
   Google Scholar
• Statistics Canada. (2020a). Canada at a glance 2020: Population. https://www150.statcan.gc.ca/n1/pub/12-581-x/2020001/pop-eng.htm
   Google Scholar
• Statistics Canada. (2020b). Table 3 Median after-tax income, Canada and provinces, 2014 to 2018. https://www150.statcan.gc.ca/n1/daily-quotidien/200224/t003a-eng.htm
   Google Scholar
• Statistics Canada. (2022). Population estimates, July 1, by census metropolitan area and census agglomeration, 2016 boundaries. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710013501
   Google Scholar
• Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010). HIV and risk environment for injecting drug users: The past, present, and future. The Lancet, 376(9737), 268–284. https://doi.org/10.1016/S0140-6736(10)60884-7
   PubMed Web of Science ®Google Scholar
• Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Sage Publications, Inc.
   Google Scholar
• Strike, C., & Watson, T. M. (2017). Education and equipment for people who smoke crack cocaine in Canada: Progress and limits. Harm Reduction Journal, 14(1), 17–17. https://doi.org/10.1186/s12954-017-0144-3
   PubMedGoogle Scholar
• Tofighi, B., Williams, A. R., Chemi, C., Suhail-Sindhu, S., Dickson, V., & Lee, J. D. (2019). Patient barriers and facilitators to medications for opioid use disorder in primary care. Substance Use & Misuse, 54(14), 2409–2419. https://doi.org/10.1080/10826084.2019.1653324
   PubMed Web of Science ®Google Scholar
• Vickerman, P., Page, K., Maher, L., & Hickman, M. (2014). Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C prevention: Building an evidence base? Addiction, 109(12), 2060–2061. http://doi.org/10.1111/add.12750
   PubMed Web of Science ®Google Scholar
• Vipler, S., Hayashi, K., Milloy, M.-J., Wood, E., Nosova, E., Kerr, T., & Ti, L. (2018). Use of withdrawal management services among people who use illicit drugs in Vancouver. Canada. Substance Abuse Treatment, Prevention and Policy, 13(27), 1–8. https://doi.org/10.1186/s13011-018-0164-3
   PubMedGoogle Scholar
• Watson, B. (2022, February 9). Over 2,200 people died in B.C. in 2021 due to illicit-drug overdoses, coroner reports. CBC News. https://www.cbc.ca/news/canada/british-columbia/bc-toxic-drugs-deaths-december2021-1.6344991
   Google Scholar
• Wisdom, J. P., Cavaleri, M., Gogel, L., & Nacht, M. (2011). Barriers and facilitators to adolescent drug treatment: Youth, family, and staff reports. Addiction Research & Theory, 19(2), 179–188. https://doi.org/10.3109/16066359.2010.530711
   Web of Science ®Google Scholar